The first UK clinical trial of a potential therapeutic for Rett Syndrome has been activated today under the leadership of Dr Paramala Santosh, Head of the Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) at the world class Clinical Research Facility at King’s College Hospital in London.